Quetiapine can cause massive, reversible elevations in serum creatine kinase even in neuroleptic-naïve patients, suggesting a need for CK assessment if myalgia occurs.
Answers are grounded in this paper and cite their sources.
May support CK assessment if myalgia occurs on quetiapine; hypothesis-generating and should not yet change practice.
Massive elevations of serum creatine kinase (CK) can occur in a significant number of patients treated with neuroleptics in the absence of neuroleptic malignant syndrome (NMS). We report two cases of CK-elevations associated with quetiapine treatment, which disappeared after drug discontinuation. To our knowledge, case number one is the first case of quetiapine-induced CK elevation in a neuroleptic-naïve patient. We thus suggest CK assessment when myalgia occurs with neuroleptic treatment.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: